ILLIMIS Trademark
Serial Number: 79342263 • Registration: 7095522
ILLIMIS is a trademark filed by
Illimis Therapeutics, Inc.
on March 17, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Jong Park The PL Law Group, PLLC
13800 Coppermine Rd.
FL1-3
Herndon
VA 20171
Trademark Details
Filing Date
March 17, 2022
Registration Date
July 4, 2023
Published for Opposition
April 18, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 31, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 6, 2023 FICS
FINAL DISPOSITION PROCESSED
Oct 6, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 4, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 4, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 4, 2023 R.PR
LIMITATION FROM THE IB EXAMINED AND ENTERED
May 10, 2023 LIME
NOTIFICATION PROCESSED BY IB
Apr 25, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 18, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 5, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 5, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 29, 2023 NONP
REFUSAL PROCESSED BY IB
Mar 21, 2023 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2023 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 27, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 27, 2023 RFRR
LIMITATION OF GOODS RECEIVED FROM IB
Feb 13, 2023 LIMG
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 1, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 31, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 29, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 14, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 10, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 9, 2022 REPR
